OS2.3 A mutation-specific vaccination approach for Histon H3.3 K27M-mutated gliomas

For malignant gliomas, progress in molecular diagnostics such as genome-wide sequencing led to identification of subgroup-defining genetic alterations representing promising immunotherapeutic targets especially for personalized vaccination strategies. One example for an oncogenic mutation occurring...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Ochs, K., Ott, M., Bunse, L., Sahm, F., Bunse, T., Deimling, A. von, Wick, W., Platten, M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2016
Pynciau:
OS2 Immunology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5782513/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.013
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg